Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population

Affiliations

• ¹ CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France; INSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France. Electronic address: dimeglio.c@chu-toulouse.fr.
• ² CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France; INSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France.
• ³ Occupational Diseases Department, Toulouse University Hospital, 31000 Toulouse, France; Inserm UMR 1295: Center for research in population health (CERPOP)- Department of Epidemiology and Public Health, Toulouse. University of Toulouse III F-31073, 37, allées Jules Guesde, 31073 Toulouse, France.
• ⁴ CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France.
• ⁵ INSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; Infectious and Tropical Diseases Department, Toulouse University Hospital, 31300 Toulouse, France.
• ⁶ Inserm UMR 1295: Center for research in population health (CERPOP)- Department of Epidemiology and Public Health, Toulouse. University of Toulouse III F-31073, 37, allées Jules Guesde, 31073 Toulouse, France; CHU Toulouse (Toulouse University Hospital) Geriatric Department, Hôpital Purpan Pavillon Leriche Place Baylac, 31300 Toulouse, France.